Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277827
Max Phase: Preclinical
Molecular Formula: C23H32N6O14
Molecular Weight: 616.54
Associated Items:
ID: ALA5277827
Max Phase: Preclinical
Molecular Formula: C23H32N6O14
Molecular Weight: 616.54
Associated Items:
Canonical SMILES: C/C=C1\CN(C(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)[C@@H](O)COC(N)=O)[C@H]2O[C@@H](n3cc(CO)c(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@H]1C(=O)O
Standard InChI: InChI=1S/C23H32N6O14/c1-2-7-3-28(12(7)21(38)39)19(37)11(26-18(36)10(24)13(32)9(31)6-42-22(25)40)16-14(33)15(34)20(43-16)29-4-8(5-30)17(35)27-23(29)41/h2,4,9-16,20,30-34H,3,5-6,24H2,1H3,(H2,25,40)(H,26,36)(H,38,39)(H,27,35,41)/b7-2+/t9-,10-,11-,12+,13+,14-,15+,16+,20+/m0/s1
Standard InChI Key: PQAGMWMKVWTHJU-QPHAYPEISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 616.54 | Molecular Weight (Monoisotopic): 616.1976 | AlogP: -6.48 | #Rotatable Bonds: 11 |
Polar Surface Area: 330.29 | Molecular Species: ACID | HBA: 15 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.41 | CX Basic pKa: 7.23 | CX LogP: -8.79 | CX LogD: -9.14 |
Aromatic Rings: 1 | Heavy Atoms: 43 | QED Weighted: 0.10 | Np Likeness Score: 1.06 |
1. Serpi M, Ferrari V, Pertusati F.. (2016) Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?, 59 (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325] |
Source(1):